The application of anti-Beclin-1 antibody-conjugated liposomes in ischemic myocardium exhibits extensive research potential. By targeting Beclin-1, it is possible to effectively regulate the process of autophagy and promote the survival and repair of myocardial cells. In in vivo experiments, it has shown good biocompatibility and targeting ability, aiding in the precise delivery of therapeutic drugs. In the future, this technology may provide new strategies for the treatment of ischemic heart disease and has the potential to improve patient outcomes.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-2936z | Mouse Anti-BECN1 Recombinant Antibody (clone 2H3) | WB, FC, ICC, IF, IHC | Mouse IgG1 |
MOB-0252CT | Mouse Anti-BECN1 Recombinant Antibody (clone 3B5) | ELISA, FC, IHC-P, WB | Mouse IgG1 |
ZG-0049J | Mouse Anti-BECN1 Recombinant Antibody (clone 5A11) | IHC-P, IF | Mouse IgG |
VS3-WK957 | Mouse Anti-BECN1 Recombinant Antibody (VS3-WK957) | WB | Mouse IgG |
VS3-XY3276 | Rabbit Anti-BECN1 Recombinant Antibody (clone R07-2K6) | WB, IHC-P, ICC, IF, IP | Rabbit IgG |
There are currently no Customer reviews or questions for VS-1024-FY208. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.